FDA Approves Zostavax Vaccine To Prevent Shingles In Individuals 50 To 59 Years Of Age
The Food and Drug Administration (FDA) today approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older. In the United States shingles affects approximately 200,000 healthy people between the ages of 50 and 59, per year. It is a disease caused by ...

FDA Considers New Rules To Speed Up Confirmatory Trials Of Cancer Drugs Granted Accelerated Approval
Since 1992, the U.S. Food and Drug Administration has granted accelerated approval to 47 new indications for 35 cancer drugs and in more than half the cases - 26 indications - further trials have confirmed the benefits of the drugs. But the agency has concerns about the length of time some drugs have remained on the market without confirmation of their benefits, according to a review article ...